{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T01:00:38Z","timestamp":1775523638358,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.prp.2008.01.003","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T11:43:52Z","timestamp":1205408632000},"page":"359-365","source":"Crossref","is-referenced-by-count":10,"title":["CD117 expression in normal, neoplastic, inflammatory, and reactive lesions of the thyroid"],"prefix":"10.1016","volume":"204","author":[{"given":"Oguz","family":"Aydin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Kefeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bedri","family":"Kandemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.prp.2008.01.003_bib1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10024-002-0077-y","article-title":"Expression of c-kit in Ewing family of tumors: a comparison of different immunohistochemical protocols","volume":"7","author":"Ahmed","year":"2004","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.prp.2008.01.003_bib2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0046-8177(98)90066-1","article-title":"Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders","volume":"29","author":"Arber","year":"1998","journal-title":"Hum. Pathol."},{"issue":"8","key":"10.1016\/j.prp.2008.01.003_bib3","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1182\/blood.V86.8.3132.3132","article-title":"Expression of stem cell factor and its receptor by human neuroblastoma cells and tumors","volume":"86","author":"Beck","year":"1995","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.prp.2008.01.003_bib4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood.V92.2.596","article-title":"The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL)","volume":"92","author":"Bene","year":"1998","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.prp.2008.01.003_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jnci\/djh004","article-title":"Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression","volume":"96","author":"Beppu","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2008.01.003_bib6","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1158\/1078-0432.CCR-03-0664","article-title":"Expression and mutational status of c-kit in small cell lung cancer: prognostic relevance","volume":"10","author":"Boldrini","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.prp.2008.01.003_bib7","doi-asserted-by":"crossref","first-page":"538","DOI":"10.5858\/2004-128-538-TSOKCI","article-title":"The spectrum of KIT (CD117) immunoreactivity in lung and pleural tumors: a study of 96 cases using a single-source antibody with a review of the literature","volume":"128","author":"Butnor","year":"2004","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2008.01.003_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11060-005-2318-1","article-title":"CD117 expression in glial tumors","volume":"75","author":"Cetin","year":"2005","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.prp.2008.01.003_bib9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.prp.2006.04.007","article-title":"Kit expression in spindle cell rhabdomyosarcoma can possibly create a different approach for its tumorigenesis and therapy","volume":"202","author":"Diniz","year":"2006","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2008.01.003_bib10","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.prp.2008.01.003_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1158\/1078-0432.CCR-0778-03","article-title":"Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor\/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis","volume":"10","author":"Gonzalez","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2008.01.003_bib12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/hupa.2002.124124","article-title":"Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations","volume":"33","author":"Heinrich","year":"2002","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2008.01.003_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.prp.2008.01.003_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1309\/LX9U-F7P0-UWDH-8Y6R","article-title":"Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution","volume":"117","author":"Hornick","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2008.01.003_bib15","first-page":"2926","article-title":"Clinicopathologic assessment of post radiation sarcomas: KIT as a potential treatment target","volume":"9","author":"Komdeur","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2008.01.003_bib16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/sj.onc.1207145","article-title":"Expression of the c-kit receptor characterizes a subset of neuroblastomas with favorable prognosis","volume":"23","author":"Krams","year":"2004","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.prp.2008.01.003_bib17","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0002-9440(10)64850-X","article-title":"The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit","volume":"157","author":"Landuzzi","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.prp.2008.01.003_bib18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1089\/107999099313172","article-title":"The c-kit receptor and its ligand stem cell factor in childhood malignant lymphoid precursors","volume":"19","author":"Legitimo","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.prp.2008.01.003_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/modpathol.3800108","article-title":"A distinct expression pattern and point mutation of c-kit in papillary renal cell carcinomas","volume":"17","author":"Lin","year":"2004","journal-title":"Mod. Pathol."},{"issue":"26","key":"10.1016\/j.prp.2008.01.003_bib20","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.3748\/wjg.v12.i26.4161","article-title":"Clinicopathological and immunohistochemical analysis of gastrointestinal stromal tumor","volume":"12","author":"Liu","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2008.01.003_bib21","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.prp.2008.01.003_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00000478-200204000-00012","article-title":"Expression of KIT (CD117) in angiomyolipoma","volume":"26","author":"Makhlouf","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"issue":"12","key":"10.1016\/j.prp.2008.01.003_bib23","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.humpath.2006.06.022","article-title":"A novel tumor marker, Niban, is expressed in subsets of thyroid tumors and Hashimoto's thyroiditis","volume":"37","author":"Matsumoto","year":"2006","journal-title":"Hum. Pathol."},{"issue":"22","key":"10.1016\/j.prp.2008.01.003_bib24","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/jnci\/94.22.1673","article-title":"Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity","volume":"94","author":"Merchant","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2008.01.003_bib25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1440-1827.2005.01902.x","article-title":"Expression of KIT, EGFR, HER\u20132 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach","volume":"55","author":"Murakawa","year":"2005","journal-title":"Pathol. Int."},{"issue":"12","key":"10.1016\/j.prp.2008.01.003_bib26","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1053\/hupa.2002.129199","article-title":"Analysis of c-kit protein expression in small-cell lung carcinoma and its implication for prognosis","volume":"33","author":"Naeem","year":"2002","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2008.01.003_bib27","first-page":"1787","article-title":"Transformation of thyroid epithelium is associated with loss of c-kit receptor","volume":"55","author":"Natali","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2008.01.003_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00001813-200304000-00009","article-title":"Immunohistochemical expression of receptor-tyrosine kinase c-kit protein in invasive ductal carcinoma of the pancreas","volume":"14","author":"Nio","year":"2003","journal-title":"Anticancer Drugs"},{"issue":"4","key":"10.1016\/j.prp.2008.01.003_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.mph.0000157790.81329.47","article-title":"Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular and genomic study of 15 cases and review of the literature","volume":"27","author":"Prakash","year":"2005","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.prp.2008.01.003_bib30","volume":"vol. I","author":"Rosai","year":"2004"},{"issue":"10","key":"10.1016\/j.prp.2008.01.003_bib31","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/01.MP.0000089780.30006.DE","article-title":"Kit expression in small cell carcinomas of the lung: effects of chemotherapy","volume":"16","author":"Rossi","year":"2003","journal-title":"Mod. Pathol."},{"issue":"9","key":"10.1016\/j.prp.2008.01.003_bib32","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/cncr.20986","article-title":"Expression of EGFR, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases","volume":"103","author":"Sato","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2008.01.003_bib33","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/modpathol.3800463","article-title":"Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications","volume":"18","author":"Sever","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2008.01.003_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","article-title":"Thyroid carcinoma","volume":"361","author":"Sherman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2008.01.003_bib35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1158\/1078-0432.CCR-0597-3","article-title":"KIT(CD117)\u2014positive breast cancers are infrequent and lack KIT gene mutations","volume":"10","author":"Simon","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2008.01.003_bib36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00000478-200204000-00011","article-title":"C-kit expression in pediatric solid tumors: a comparative immunohistochemical study","volume":"26","author":"Smithey","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2008.01.003_bib37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1507\/endocrj.42.723","article-title":"c-Kit proto-oncogene is more likely to lose expression in differentiated thyroid carcinoma than three thyroid-specific genes: thyroid peroxidase, thyroglobulin, and thyroid stimulating hormone receptor","volume":"42","author":"Tanaka","year":"1995","journal-title":"Endocr. J."},{"issue":"2","key":"10.1016\/j.prp.2008.01.003_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ijc.11187","article-title":"c-Kit is preferentially expressed in MYCN amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571","volume":"106","author":"Vitali","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2008.01.003_bib39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.onc.1206153","article-title":"Overexpression of KIT in chromophobe renal cell carcinoma","volume":"22","author":"Yamazaki","year":"2003","journal-title":"Oncogene"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033808000241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033808000241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,5]],"date-time":"2021-09-05T21:34:30Z","timestamp":1630877670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033808000241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0344033808000241"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2008.01.003","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}